VICTORIA, British Columbia (AP) _ Aurinia Pharmaceuticals Inc. (AUPH) on Thursday reported a loss of $3.3 million in its fourth quarter.
The Victoria, British Columbia-based company said it had a loss of 4 cents per share.
The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 14 cents per share.
The biotechnology company posted revenue of $31,000 in the period, which fell short of Street forecasts. Four analysts surveyed by Zacks expected $50,000.
For the year, the company reported that its loss widened to $70.8 million, or 92 cents per share. Revenue was reported as $420,000.
Aurinia shares have climbed 18 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $5.36, a decrease of 31 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AUPH at https://www.zacks.com/ap/AUPH